Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laila Shehata

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
American Journal of Medical Genetics. Part A|September 25, 2014
ERCC6 dysfunction presenting as progressive neurological decline with brain hypomyelinationLaila Shehata, Dimitre R Simeonov, Anja Raams, et al.
Cell Host & Microbe|March 12, 2021
TGFβ restricts expansion, survival, and function of T cells within the tuberculous granulomaBenjamin H Gern, Kristin N Adams, Courtney R Plumlee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2020
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccineAnna Z Wec, Denise Haslwanter, Yasmina N Abdiche, et al.
Research Square|August 21, 2020
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19Lauren B Rodda, Jason Netland, Laila Shehata, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19Lauren B Rodda, Jason Netland, Laila Shehata, et al.
Cell|December 9, 2020
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19Lauren B Rodda, Jason Netland, Laila Shehata, et al.
Cell Reports. Medicine|October 7, 2022
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogensJohn C Kraft, Minh N Pham, Laila Shehata, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|November 8, 2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Journal of Medical Genetics. Part A|September 25, 2014
ERCC6 dysfunction presenting as progressive neurological decline with brain hypomyelinationLaila Shehata, Dimitre R Simeonov, Anja Raams, et al.
Cell Host & Microbe|March 12, 2021
TGFβ restricts expansion, survival, and function of T cells within the tuberculous granulomaBenjamin H Gern, Kristin N Adams, Courtney R Plumlee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2020
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccineAnna Z Wec, Denise Haslwanter, Yasmina N Abdiche, et al.
Research Square|August 21, 2020
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19Lauren B Rodda, Jason Netland, Laila Shehata, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19Lauren B Rodda, Jason Netland, Laila Shehata, et al.
Cell|December 9, 2020
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19Lauren B Rodda, Jason Netland, Laila Shehata, et al.
Cell Reports. Medicine|October 7, 2022
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogensJohn C Kraft, Minh N Pham, Laila Shehata, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|November 8, 2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Pageof 2